Survival benefit from bevacizumab in newly diagnosed glioblastoma (GBM) according to transcriptional subclasses Meeting Abstract
| Authors: | Huse, J. T.; Beal, K.; Zhang, J.; Kastenhuber, E. R.; Kaley, T. J.; Abrey, L. E.; Gutin, P. H.; Brennan, C. W.; Omuro, A. M. P. |
| Abstract Title: | Survival benefit from bevacizumab in newly diagnosed glioblastoma (GBM) according to transcriptional subclasses |
| Meeting Title: | 49th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 31 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2013 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2013-05-20 |
| Language: | English |
| ACCESSION: | WOS:000335419600718 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2013.31.15_suppl.2057 |
| Notes: | Meeting Abstract: 2057 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
